Biblio

Author Title Type [ Year(Asc)]
Filters: Author is He, Yi  [Clear All Filters]
2021
Wang J, Wang Q, Zhang H, He Y, Huang Y, Zhang R, Wei J, Ma Q, Pang A, Yang D, et al. Moderate to severe marrow fibrosis as a more advanced risk factor for MDS and MDS-AML patients with excess of blasts receiving allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther. 2021.
Li Y, He Y, Chen G, Huang Z, Yi C, Zhang X, Deng F, Yu D. Selenomethionine protects oxidative-stress-damaged bone-marrow-derived mesenchymal stem cells via an antioxidant effect and the PTEN/PI3K/AKT pathway. Exp Cell Res. 2021:112864.
2020
Li T, Jin W, He Y, Zhou Z. Generation of PRMT6 homozygous knockout human embryonic stem cell lines. Stem Cell Res. 2020;50:102136.
2019
He Y, Li Y, Chen G, Wei C, Zhang X, Zeng B, Yi C, Wang C, Yu D. Concentration-dependent cellular behavior and osteogenic differentiation effect induced in bone marrow mesenchymal stem cells treated with magnetic graphene oxide. J Biomed Mater Res A. 2019.
Cao Y-G, He Y, Zhang S-D, Liu Z-X, Zhai W-H, Ma Q-L, Pang A-M, Wei J-L, Yang D-L, Huang Y, et al. Conditioning regimen of 5-day decitabine administration for allogeneic stem cell transplantation in patients with myelodysplastic syndrome and myeloproliterative neoplasms. Biol Blood Marrow Transplant. 2019.
Zhang X, Wei C, Li Y, Li Y, Chen G, He Y, Yi C, Wang C, Yu D. Dose-dependent cytotoxicity induced by pristine graphene oxide nanosheets for potential bone tissue regeneration. J Biomed Mater Res A. 2019.
Zhang S, Zhang P, Wang Z, Liu L, He Y, Jiang E, Wei J, Yang D, Zhang R, Zhai W, et al. Posaconazole oral suspension as salvage therapy for invasive fungal disease in patients with hematological diseases. Future Microbiol. 2019.
2016
He Y, Li H, Zhang F, Zhang G, Tang X, Zhu T, Huang N, Li X. Immunotherapeutic effects of lymphocytes co-cultured with human cord blood-derived multipotent stem cells transplantation on APP/PS1 mice. Behav Brain Res. 2016.
2014
Long Z-J, Hu Y, Li X-D, He Y, Xiao R-Z, Fang Z-G, Wang D-N, Liu J-J, Yan J-S, Huang R-W, et al. ATO/ATRA/Anthracycline-Chemotherapy Sequential Consolidation Achieves Long-Term Efficacy in Primary Acute Promyelocytic Leukemia. PLoS One. 2014;9(8):e104610.
Cai X, Wei J, He Y, Yang D, Jiang E, Huang Y, Han M, Feng S. A modified busulfan and cyclophosphamide preparative regimen for allogeneic transplantation in myeloid malignancies. Int J Clin Pharm. 2014.